Anderson Schock
Stock Analyst at B. Riley Securities
(4.03)
# 1,715
Out of 5,023 analysts
42
Total ratings
59.5%
Success rate
16.5%
Average return
Main Sectors:
Stocks Rated by Anderson Schock
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VREX Varex Imaging | Downgraded: Hold | $18 → $19 | $18.46 | +2.38% | 5 | Aug 10, 2026 | |
| LFMD LifeMD | Reiterated: Buy | $10 → $8 | $2.74 | +191.97% | 2 | Aug 6, 2026 | |
| INFU InfuSystem Holdings | Rated: Buy | $12 → $20 | $13.16 | +51.98% | 3 | Aug 5, 2026 | |
| XGN Exagen | Rated: Buy | $8 → $12 | $8.17 | +46.88% | 5 | Aug 5, 2026 | |
| ANIK Anika Therapeutics | Reiterated: Buy | $18 → $21 | $19.10 | +9.95% | 4 | Jul 30, 2026 | |
| NUTX Nutex Health | Initiated Coverage: Buy | $290 | $216.50 | +33.95% | 1 | Jun 26, 2026 | |
| CLPT ClearPoint Neuro | Reiterated: Buy | $20 → $30 | $10.90 | +175.36% | 5 | Jun 17, 2026 | |
| OBIO Orchestra BioMed Holdings | Reiterated: Buy | $10 | $5.95 | +68.07% | 1 | May 18, 2026 | |
| ELMD Electromed | Reiterated: Buy | $38 → $40 | $28.10 | +42.35% | 2 | May 13, 2026 | |
| OPRX OptimizeRx | Reiterated: Buy | $11 → $10 | $8.57 | +16.69% | 4 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $32 → $36 | $22.10 | +62.90% | 4 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $4 | $0.4346 | +820.39% | 1 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $14 | $10.88 | +28.68% | 1 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $1.16 | +331.03% | 1 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $5.97 | +134.51% | 3 | Jan 21, 2026 |
Varex Imaging
Aug 10, 2026
Downgraded: Hold
Price Target: $18 → $19
Current: $18.46
Upside: +2.38%
LifeMD
Aug 6, 2026
Reiterated: Buy
Price Target: $10 → $8
Current: $2.74
Upside: +191.97%
InfuSystem Holdings
Aug 5, 2026
Rated: Buy
Price Target: $12 → $20
Current: $13.16
Upside: +51.98%
Exagen
Aug 5, 2026
Rated: Buy
Price Target: $8 → $12
Current: $8.17
Upside: +46.88%
Anika Therapeutics
Jul 30, 2026
Reiterated: Buy
Price Target: $18 → $21
Current: $19.10
Upside: +9.95%
Nutex Health
Jun 26, 2026
Initiated Coverage: Buy
Price Target: $290
Current: $216.50
Upside: +33.95%
ClearPoint Neuro
Jun 17, 2026
Reiterated: Buy
Price Target: $20 → $30
Current: $10.90
Upside: +175.36%
Orchestra BioMed Holdings
May 18, 2026
Reiterated: Buy
Price Target: $10
Current: $5.95
Upside: +68.07%
Electromed
May 13, 2026
Reiterated: Buy
Price Target: $38 → $40
Current: $28.10
Upside: +42.35%
OptimizeRx
May 13, 2026
Reiterated: Buy
Price Target: $11 → $10
Current: $8.57
Upside: +16.69%
May 7, 2026
Upgraded: Buy
Price Target: $32 → $36
Current: $22.10
Upside: +62.90%
Mar 31, 2026
Initiated Coverage: Buy
Price Target: $4
Current: $0.4346
Upside: +820.39%
Feb 26, 2026
Downgraded: Hold
Price Target: $14
Current: $10.88
Upside: +28.68%
Feb 10, 2026
Initiated Coverage: Buy
Price Target: $5
Current: $1.16
Upside: +331.03%
Jan 21, 2026
Reiterated: Buy
Price Target: $14
Current: $5.97
Upside: +134.51%